ResMed | RMD - Nettoeinkommen

Aktienkurs
227.97
Täglich Wechseln
1.98 0.88%
Monatlich
-9.40%
Jährlich
2.27%
Q1 Prognose
219.21




Nettoeinkommen Veränderung Datum
Ansell USD 88.8M 65.5M 2025-12
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
CSL USD 401M 96.5M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Fisher Paykel Healthcare NZD 213M 11M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Hologic USD 179.1M 8.2M 2025-12
Idexx Laboratories USD 248.19M 26.42M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Philips EUR 395M 211M 2025-12
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 392.59M 44.06M 2025-12
Sigma Healthcare AUD -6.72M 10.02M 2024-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12
Steris USD 192.9M 1000K 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12